“Equine basal cell tumors: 6 cases (1985-1999)”.

This small case series describes six horses diagnosed with rare, benign basal cell tumors between 1985 and 1999, detailing how these skin masses often mimicked sarcoids or melanoma on visual exam. Complete surgical excision was curative in the cases with follow-up, highlighting the value of histologic diagnosis and surgery.

Study snapshot

• Design: Retrospective case series of equine basal cell tumors identified over a 15-year period (1985–1999).
• Sample: Six horses with clinically evident skin masses later confirmed as basal cell tumors.
• Aim: Describe clinical appearance, diagnostic challenges, and outcomes after surgical removal.

What are equine basal cell tumors?

• Nature: Benign skin tumors arising from basal cells of the epidermis or adnexal structures; considered rare in horses.
• Behavior: Typically slow-growing, non-metastatic lesions that can be cured with complete excision.

Clinical appearance in this series

• Morphology: Well-circumscribed, freely moveable, firm, raised papules, nodules, or masses.
• Size range: 0.6 to 5 cm in diameter.
• Ulceration: Present in five of the six tumors.
• Chronicity: Lesions were noted clinically from as little as 1 week up to 3 years before excision.
• Signalment: Affected horses ranged from 6 to 26 years of age.

Common misdiagnoses and differential considerations

• Gross misdiagnosis: Based on appearance alone, most lesions were called sarcoids; one was diagnosed as melanoma.
• Implication: Visual inspection is insufficient; basal cell tumors can closely mimic more common equine skin tumors.
• Practical takeaway: Histopathologic examination is essential to distinguish basal cell tumors from sarcoids and melanocytic tumors.

Diagnosis and confirmation

• Primary method: Definitive diagnosis relies on histologic evaluation after biopsy or excision.
• Reason: Overlap in gross features with other equine skin tumors makes clinical diagnosis unreliable.

Treatment and outcomes

• Intervention: Complete surgical excision of the mass.
• Efficacy: In four horses with available follow-up, no recurrence was observed 4 months to 2 years post-removal.
• Clinical message: When margins are complete, surgical excision appears curative for these benign tumors.

Clinical relevance

• Recognition: Consider basal cell tumor in the differential for firm, well-circumscribed, freely moveable, and often ulcerated equine skin masses.
• Management: Do not rely solely on gross appearance; obtain histologic confirmation to guide appropriate treatment.
• Prognosis: Excellent with complete excision; low likelihood of recurrence reported in this series.

Limitations of the report

• Sample size: Only six cases, limiting generalizability.
• Follow-up: Outcome data available for four horses; long-term control beyond 2 years not reported.
• Scope: Retrospective design with limited detail on tumor locations and surgical margins.

Key takeaways

• Basal cell tumors in horses are rare but can closely resemble sarcoids or melanoma on gross exam.
• Histopathology is required for accurate diagnosis.
• Complete surgical excision is typically curative, with no recurrences reported in the followed cases up to 2 years.
• Consider early removal of suspicious, well-circumscribed, movable, and ulcerated lesions to achieve cure and avoid chronic ulceration.